An adenovirus mutant lacking the expression of the large E1B protein (DE1B) has been reported to replicate selectively in cells lacking the expression of functionally wild-type (wt) p53. Based on these results the DE1B or ONYX-015 virus has been proposed to be an oncolytic virus which might be useful to treat p53-de®cient tumors. Recently however, contradictory results have been published indicating that p53-dependent cell death is required for productive adenovirus infection. Since there is an urgent need for new methods to treat aggressive, mutant p53-expressing primary tumors and their metastases we carefully examined adenovirus replication in human cells to determine whether or not the DE1B virus can be used for tumor therapy. The results we present here show that not all human tumor cell lines take up adenovirus eciently. In addition, we observed inhibition of the expression of adenovirus early proteins in tumor cells. We present evidence that these two factors rather than the p53 status of the cell determine whether adenovirus infection results in lytic cell death. Furthermore, the results we obtained by infecting a panel of dierent tumor cell lines show that viral spread of the DE1B is strongly inhibited in almost all p53-pro®cient and -de®cient cell lines compared to the wt virus. We conclude that the eciency of the DE1B virus to replicate eciently in tumor cells is determined by the ability to infect cells and to express the early adenovirus proteins rather than the status of p53.
Introduction
The p53 tumor suppressor protein has been shown to be involved in a great number of biological processes. Mutation of the gene has serious consequences for the normal functioning of the cell and these mutations often lead to very aggressive tumors. Furthermore, several human DNA viruses, such as adenovirus, human papilloma virus and SV40, inactivate p53 to allow ecient replication. For adenovirus, it was shown that the large E1B/55 kDa protein is involved in this inactivation. This has led to the hypothesis that an adenovirus mutant lacking the expression of the large E1B protein selectively replicates in p53 defective cells (Bischo et al., 1996; Heise et al., 1997) . Indeed it was shown that lytic infection of the DE1B virus was poorly supported by the wt p53-containing RKO colon carcinoma cell line, but strongly by a mutant p53 expressing stable transfectant (Bischo et al., 1996) . However, cell lines expressing wt p53 may also support lytic infection by the DE1B virus but in these cases it was observed that p53 was functionally defective (Heise et al., 1997) . In addition, it has been reported that intravenous injection of the DE1B virus in nude mice caused regression of human xenografts. This eect could signi®cantly be enhanced when the injection of the adenovirus mutant was followed by administration of anti tumor agents like 5-¯uorouracil or cisplatin (Heise et al., 1997) . Based on these results important clinical applications can be envisioned for the use of the DE1B virus. The adenovirus mutant might selectively kill tumor cells of patients expressing mutant p53 or completely lacking p53 expression while leaving normal cells unaected. If the adenovirus mutant can successfully be developed into a new method for tumor therapy a broad range of tumors might be targeted by the adenovirus mutant since p53 is the most frequently mutated gene in human tumors (Hollstein et al., 1991) . Moreover, since p53 mutant tumors are very often more aggressive and less responsive to the standard therapies, this speci®c therapy would be a major step forward in the treatment of these tumors.
In contrast to the results published by Bischo and Heise and coworkers (Bischo et al., 1996) , Hall and colleagues reported recently that wt p53 is required for productive adenovirus infection (Hall et al., 1998) . In their assays wt adenovirus infection causes only cytopathic eects (CPE) in cells expressing wt p53. In cells expressing mutant p53 virus production was observed but without measurable cell death. In addition, Goodrum and Ornelles reported that the phase of the cell cycle rather than the status of p53 determines whether the DE1B virus can lytically infect cells (Goodrum and Ornelles, 1997) .
The DE1B virus as ONYX-015, is currently used as an oncolytic virus in phase I clinical trials for several tumor types (pancreatic carcinoma, colon metastasis and ovarian carcinoma) and in phase II clinical trials for head and neck tumors. Since contradictory results have been reported about the conditions under which the adenovirus mutant can replicate we investigated which parameters are of importance for lytic infection by the DE1B virus. We reasoned that for proper therapy by this adenovirus mutant tumor cells should be infective by adenoviruses, should support replication, should produce sucient viral burst for reinfection of neighboring cells and the infected cells should be killed by the virus. We therefore measured these parameters in several tumor cell lines and in dierent primary cell types. For the analysis of the infectivity we used a b-galactosidase-expressing, replication-de®cient adenovirus. Replication and virus spread was examined by measuring the expression of the late adenovirus protein hexon and with a previously described CPE assay we tested whether the infected cells were killed by the virus. Our results show that there is a strong variation in the infectivity of dierent human cell lines and primary cells by adenovirus. Furthermore, replication and virus spread of the DE1B virus is equally inhibited in p53 pro®cient as well as de®cient tumor cells. In addition, we provide evidence that wt p53 is not required for adenovirus induced cell death.
Results

Infectivity of dierent human cell types
The ®rst factor to determine the use of the DE1B adenovirus for clinical application is the ecient uptake of the virus by tumor cells in general. To examine the infectivity of dierent human cell types, infections were performed with the replication incompetent CMVLacZ virus in which the adenovirus E1 region has been replaced by the E. Coli lacZ gene placed behind the CMV promoter (Kolls et al., 1994) . The cells were either mock infected or infected with a MOI (multiplicity of infection) of 1, 10 or 100 PFU's (plaque forming units) CMVLacZ virus per cell. For cell types with a low infection eciency also a concentration of 1000 PFU's per cell has been used. At 24 h postinfection the cells were ®xed and analysed by bgalactosidase staining. Figure 1a shows an overview of the infectivity of a number of dierent human tumor cell lines. The highest infection eciency was found for the cervix carcinoma cell line C33A and the mammary carcinoma cell line MD468, both expressing mutant p53 (Nigro et al., 1989b; Schener et al., 1991) . In these two cases, already after infection with 10 PFU's per cell all cells stained positive for b-galactosidase. By contrast to these two highly infective cell lines the keratinocyte cell line HACAT, also expressing mutant p53 (Lehman et al., 1993) , showed a very low infectivity. Even after infection with a MOI of 1000 PFU's per cell only a part of the cells stained positive. Two osteosarcoma cell lines with wt p53 (U2OS) (Diller et al., 1990) or without p53 expression (Saos2) (Chandar et al., 1992) were analysed. A high infection eciency was observed for the U2OS cells while the infectivity of the Saos2 cells was a bit lower. Two other tumor cell lines, the rhabdoid kidney tumor cell line G401 (p53 wt) (Weissman et al., 1987; Steegenga et al., unpublished data) and the hepatoma cell line Hep3B (p537/7) (Puisieux et al., 1993) , both show a high infection eciency. By comparing dierent cell lines from the same origin we found that the infectivity could signi®cantly dier within a certain tumor type. As mentioned above, the breast tumor cell line MD468 showed a very high infectivity while the results obtained with another breast tumor cell line, MCF7 (Furuwatari et al., 1998) , showed a signi®cantly lower infection eciency (Figure 1a ). In addition, while for the HACAT keratinocyte cell line a very low infectivity was found, the infection eciency of HPV-transformed keratinocytes appeared to be much higher. Since we found about the same infectivity for primary keratinocytes ( Figure 1b) as for the HPV-transformed keratinocytes ( Figure 1a) we can conclude that transformation of cells does not lead to changes in the infectivity of the cells. As can be seen in Figure 1b , for primary endothelial cells we observed an intermediate infectivity while an extreme low infection eciency was observed in primary ®broblasts (VH10).
As a control, infections were performed with the RSVLacZ adenovirus, in which the E1 region has been replaced by the E. coli LacZ gene but now placed behind the RSV long terminal repeat (StratfordPerricaudet et al., 1992) . Results obtained with this reporter virus showed again the very high infectivity of the C33A and MD468 cell lines and the very poor infectivity of the HACAT cell line and the VH10 cells (data not shown). Therefore, we can exclude that the results shown in Figure 1 are caused by variation in the activity of the CMV promoter in the dierent cell types.
In conclusion, the results obtained with the LacZ adenoviruses indicate that many, but certainly not all tumor cells contain a high infection eciency. Moreover, a factor 10 ± 100 variation in the infection eciency within the group of highly infective tumor cell lines was observed. Furthermore, our results indicate that neither the cell type nor the p53 status of the cells determine the infectivity of the cells.
Replication of the wt and DE1B virus in dierent cell types after primary infections
To examine the acute eects of the primary infection of wt or DE1B adenovirus, infections were performed on exponentially growing p53-pro®cient and -de®cient tumor cells. The cells were infected with dierent concentrations of either of the two viruses and at 24 h post-infection the cells were ®xed and the production of the late adenovirus protein hexon was analysed as a measurement for virus replication. To quantify the data, the cells incubated with the a-hexon antibody were examined by FACS analysis. As can be seen in Figure 2a , after infection of C33A cells, expressing mutant p53, with a MOI of 1, 10, or 100 PFU's per cell of either the wt of DE1B virus, the same percentage of hexon positive cells was found. These results are in agreement with earlier published data showing that the wt and DE1B virus can replicate equally well in C33A and other tumor cell lines expressing mutant p53 (Bischo et al., 1996; Heise et al., 1997) . The same infections performed on Hep3B cells, completely lacking the expression of p53, show that the replication of the DE1B virus is slightly decreased compared to the wt virus after infection with 10 PFU's per cell, whereas at 100 PFU's per cell the percentage of hexon positive cells was almost identical (Figure 2a) . Similarly, in the wt p53 expressing G401 cells we observed somewhat decreased replication of the DE1B virus compared to the wt adenovirus after infection with a MOI of 10 PFU's per cell but not after infection with 100 PFU's per cell (Figure 2a) . Replication of the DE1B virus was slightly enhanced in G401 cells stably transfected with mutant p53 (G401-mt) and fully restored to wt adenovirus levels in G401 cells stably transfected with the large E1B gene (G401-55K). Apart from measuring the percentage of hexon positive cells we also analysed the virus production in the parental G401 and the G401-mt cells after infection with the wt or DE1B virus. As can be seen in Figure 2b after infection with a MOI of 100 PFU's per cell the production of the DE1B virus is not signi®cantly reduced compared to the wt virus in the G401 cell line. No dierence in the production of the two virus types was observed in the G401-mt stable cell line although virus production in general seemed to be slightly decreased in these cells compared to the parental G401 cells.
To analyse in more detail why no signi®cant inhibition of the replication of the DE1B virus in the wt p53 expressing G401 cells was found we tested the functionality of the p53 protein in this cell line in two dierent assays. First, the parental G401 cells and the two stable transfectants were irradiated with X-ray. As is shown in Table 1 , a G1 cell cycle arrest was only observed in the parental G401 cells but not in the G401-mt and G401-55K stable transfectants compatible with the notion that the radiation induced G1 arrest is p53 dependent. In all three cell lines a strong G2 arrest was observed, which has previously been shown to be p53-independent (Steegenga et al., 1995) a resulting in a reduced number of cells in S phase. In the second assay we examined the transcriptional activity of p53 in the G401 cells in a transient transfection experiment. As can be seen in Figure 2c the luciferase activity of the p53-responsive pOLXALuc construct (Steegenga et al., 1995) is about 40-fold higher than of that of the pXALuc reporter construct (Peltenburg and Schrier, 1994) which is an identical construct but lacking the p53 responsive element. As can be seen in Figure 2c induction of the pOLXALuc construct is strongly inhibited in the G401-mt cells and comparable to the eect found in the p53-de®cient Hep3B cells. Taken together, these results indicate that p53 is functionally wild-type in the parental G401 cells and that the normal wt p53 function is lost in the G401-mt cells. Apparently, despite the functionally wt p53, replication of the DE1B virus is not severely inhibited in the G401 cells.
In addition, we analysed the replication of the wt and DE1B virus in the wt p53 expressing cell line U2OS. Since we found that adenovirus replication was slightly decreased in these cells the infections were performed with concentrations of up to 1000 PFU's per cell. We observed again slightly decreased replication of the DE1B virus in these osteosarcoma cells after infection with a MOI of 100 or 1000 PFU's per cell ( Figure 2a ). Thus, irrespective to the genetic status and the G1 cell cycle regulatory function of p53 in the tumor cell lines, we observe no or only a small decrease in hexon positive cells after DE1B infection compared to wt adenovirus infection.
To investigate whether the reported protection of primary cells for lytic infection by the DE1B virus (Heise et al., 1997) can be detected by measuring hexon staining, we infected primary keratinocytes obtained from two independent donors and primary endothelial cells with the wt and DE1B adenovirus. Indeed, infection with the DE1B virus results in a considerably lower percentage of hexon positive cells compared to wt adenovirus infection in primary keratinocytes and in primary endothelial cells (Figure 2d ). By contrast, the HPV-transformed keratinocytes support replication of the wt and DE1B virus almost equally well (Figure 2d ).
Replication of the wt and DE1B virus in dierent cell types after secondary infections
After replication of the adenovirus in the primary infected cells, the virus can spread to the surrounding cells causing a secondary infection. To analyse the role of p53 in this process, p53-pro®cient and -de®cient tumor cells were infected with a low concentration of either the wt or DE1B virus. Rather than measuring burst size by plaque assay, which is generally measured after multiple rounds of infection, we have examined re-infection of the surrounding cells by measuring the percentage of hexon positive cells at dierent time points post-infection. As can be seen in Figure 3 , slightly decreased virus spread of the DE1B virus compared to the wt adenovirus was found after infection of the mutant p53 expressing C33A cells with a MOI of 0.1 PFU's per cell. A similar experiment has been performed with G401 cells. Since we observed a lower infection eciency of the G401 cells compared to the C33A cells (see Figure 1a ) the G401 cells were infected with a MOI of 1.0 PFU per cell to reach about the same number of primary infected cells as in the case of the C33A cells. As can be seen in Figure 3 , in G401 cells virus spread by the DE1B virus was signi®cantly decreased compared to the wt adenovirus. We also analysed virus spread in G401 cells after infection with a MOI 0.1 PFU's per cell and found again a strongly reduced spread of the adenovirus mutant (data not shown). This result contrasts the results of the primary infections as shown in Figure 2a and d. To examine whether wt p53 is responsible for the decreased replication of the DE1B virus in the G401 cells a similar experiment was performed with the G401-mt stable transfectant. However, as can be seen in Figure 3 , also in the G401-mt cells, replication of the DE1B virus is strongly decreased compared to the wt virus. As a control we analysed the G401 transfectant stably expressing the large E1B protein. As expected, at each day post-infection the same percentage of hexon positive cells was found for the two viruses (Figure 3 ). With the CMV-LacZ adenovirus we checked the infectivity and did not detect a dierence between the infection eciency of the parental G401 cells and the two stable transfectants (data not shown). In addition, also in the p53-de®cient Hep3B cells we found decreased spread of the DE1B virus compared to the wt virus, again indicating that the inhibited spread of the DE1B is not due to the expression of wt p53. Inhibited replication of the DE1B virus was already found in the primary infections of the primary keratinocytes and endothelial cells. When virus spread was examined in primary keratinocytes the DE1B virus was much less ecient than the wt adenovirus (data not shown).
Adenovirus infection causes CPE in cells expressing wt and mutant p53
In the experiments described above we have examined viral replication by measuring expression of the late adenovirus protein hexon. Hall et al., have shown recently that in cells expressing mutant p53 the adenovirus can replicate and that complete virus particles are formed but that only in cells expressing wt p53 a virus-induced CPE was detectable (Hall et al., 1998) . To examine whether or not the hexon positive cells are killed by the virus we infected wt p53 expressing G401 cells with a MOI of 1, 10 or 100 PFU's per cell of either the wild-type or the DE1B virus. At day 1, 2 and 3 post-infection we measured the percentage of hexon positive cells, analysed whether a CPE was detectable and examined the p53 expression levels in the infected cells. The CPE assay we used has been described previously (Hall et al., 1998) . In brief, the total amount of protein on the infected and uninfected dishes was measured (see Materials and methods). Subsequently, the amount of protein of the uninfected control was adjusted to 100% and the percentage of protein on the infected dishes was calculated. As can be seen in Figure 4a at day 1 post-infection most of the cells infected with 100 PFU's per cell of either the wt or DE1B virus are hexonpositive but no CPE was detectable. However, with the highest virus concentration a signi®cant CPE was observed at day 2 post-infection and clearly progressed at day 3 post-infection. Apparently, the kinetics of virus replication in these cells is much faster than that of the CPE but both viruses can cause lytic infection of these cells. However, when hexon staining and the CPE was examined in the G401-mt cells the results obtained were almost identical ( Figure  4b ) which indicates that introduction of mutant p53 did not inhibit virus induced cell death in these cells. In addition, in two tumor cell lines expressing mutant p53 (C33A and MD468) we also observed hexon staining as well as CPE at day 3 post-infection (Figure 4c ) indicating again that mutant p53 does not inhibit adenovirus induced lytic infection. In contrast, in the wt p53 expressing MCF7 cells, no CPE was detectable at day 3 post-infection which might probably be due to the much lower infectivity of these cells (see Figure 1a) . When the CPE assay was performed at later time points post-infection we could detect lytic cell death (data not shown).
In the same experiments we examined the expression levels of p53 in the infected cells. We and others have shown previously that together the large E1B and the E4orf6 proteins can target p53 for active degradation in adenovirus infected cells (Querido et al., 1997; Steegenga et al., 1998) . In the wt as well as the mutant p53 expressing cell lines except for the MCF7 cells degradation of p53 was observed after wt virus infection. No down-regulation or even increased p53 expression was found after DE1B infection. At day 1 post-infection G401 and G401-mt cells infected with 100 PFU's per cell wt adenovirus show already downregulation of p53 while in the duplicate dishes no CPE was detectable. No signi®cant alterations were detectable in the actin expression levels in the same lysates.
Inhibited expression of adenovirus early proteins leads to inhibited CPE
We expanded our study to two cell lines completely lacking the expression of p53. In Hep3B cells we could clearly detect hexon positive staining as well as virus induced cell killing at day 3 post-infection (Figure 5a ). In contrast, hardly any hexon staining and no CPE could be detected in infected Saos2 cells at the same time point post-infection. As can be seen in Figure 1a the infectivity of the Saos2 cells is only slightly lower than that of the Hep3B cells so dierence in viral entry can not explain the distinction between the two cell types. One of the ®rst steps in virus replication is the production of the early adenovirus proteins and we examined whether this was comparable between the two cell types. As is shown in Figure 5b , expression of the E1A and small E1B proteins diered signi®cantly between the two cell types. Infection of Hep3B cells with a MOI of 10 PFU's per cell caused already at day 1 post-infection clear expression of both Ad E proteins. In contrast, hardly any expression of either the E1A or small E1B proteins could be detected at day 3 postinfection in the lysates of Saos2 cells infected with a MOI of 100 PFU's per cell. Even a concentration of 1000 PFU's per cell did not give the same expression levels of the Ad E proteins in Saos2 cells as could be observed after infecting the Hep3B cells with 10 PFU's per cell. Therefore, we conclude that adenovirus can enter Saos2 cells but that subsequently the expression of the early proteins is inhibited.
Discussion
The data published by Bischo et al. (1996) and Heise et al. (1997) indicated that an adenovirus mutant lacking the expression of the large E1B protein might be a new approach to treat tumors in which the wt p53 function is lost. With the use of the replication incompetent CMVLacZ marker adenovirus we examined the infectivity of dierent human tumor cell lines. Although in most cases an ecient up-take of adenovirus by the cell was observed, this was not c Figure 4 Comparison of the eects of wt and DE1B adenovirus infection on hexon staining, CPE and p53 expression in cells expressing wt or mutant p53. G401 (a) and G401-mt cells (b) were infected with increasing concentrations of either the wt or DE1B virus. At day 1, 2 and 3 post-infection cells were isolated and the percentage of hexon positive cells, the CPE and the eect on p53 expression were examined. (c) MD468, C33A and MCF7 cells were infected and on day 3 post-infection the percentage of hexon positive cells, the CPE and the eect on p53 expression were examined. Since replication of the two viruses in C33A cells is very ecient these cells were infected with lower concentrations of both viruses. The error bars represent the variation between two independent experiments found for all cell lines. A low infectivity was observed for the mammary carcinoma cell line MCF7 whereas the HACAT cell line expressing mutant p53 was found to contain an extreme low infectivity. These results indicate that not all tumors can be treated with the DE1B virus and that successful use of the adenovirus mutant will be restricted to those tumors which take up adenovirus eciently. For the entry of the adenovirus into the cell the virus ®rst binds to the coxsackievirus and adenovirus receptor (CAR) (Bergelson et al., 1997) . Subsequently, integrins are involved in the internalization of the virus into the cell (Wickham et al., 1993) . It would be interesting to ®nd out whether the expression of these proteins is correlated with the infection eciency of the cells by the adenovirus and can be used as a predictive marker for the infection eciency of the cells.
A low infectivity is not the only parameter which can inhibit adenovirus replication. We found that in Saos2 cells, which are able to take up the virus eciently, lytic infection of both the wt and the DE1B adenovirus was hardly detectable even after infection with very high concentrations of the two viruses. Western analysis showed that expression of the adenovirus early proteins E1A and small E1B was hardly detectable in the lysates of the infected cells. It is not clear what causes the inhibited expression of the Ad E proteins in the Saos2 cells, it might be that essential transcription factors are lacking or that transcription or translation inhibitors are present in these cells.
We subsequently examined the role of p53 in the replication of wt and DE1B adenovirus in primary and secondary infections. In primary infections slightly decreased replication of the DE1B virus was found in almost all tumor cells. It has previously been reported that the large E1B protein, complexed to the E4orf6 protein, enhances the transport of viral mRNA from the infected nucleus to the cytoplasm while, at the same time, inhibiting the transport of cellular mRNA (Babiss and Ginsberg, 1984; Ornelles and Shenk, 1991) . The decreased replication of the DE1B virus can be explained by the disturbance of these processes and has also been observed in other cell types as well (Yew et al., 1990) . However, in contrast to what has been reported previously, we did not observe signi®cant protection against replication of the DE1B virus in tumor cells expressing functionally wt p53. In addition, stable transfection of a p53-pro®cient tumor cell with mutant p53 resulted in loss of X-ray induced G1 cell cycle arrest but did not give rise to strongly increased replication of the DE1B virus in the transfected cells. These results suggest that wt p53 expression does not signi®cantly in¯uence the replication of the adenovirus mutant. However, at the moment additional eects of the p53 homologues p73 and p63 can not be excluded (Jost et al., 1997; Kaghad et al., 1997; Osada et al., 1998; Schmale and Bamberger, 1997) .
In contrast to the data obtained with tumor cell lines, strongly reduced replication of the DE1B virus was found in primary cells. The dierent results obtained with the primary cells and the`wt' p53 expressing tumor cells might be explained by the possible existence of an additional protein in tumor cells which can overcome the defect caused by the lack of large E1B expression or by the de®ciency of a protein other than wt p53 which prevents DE1B replication.
In secondary infections strongly reduced replication of the DE1B virus compared to the wt adenovirus was observed in a number of dierent tumor cell lines. Since we observed this reduced replication in both p53-pro®cient and -de®cient cell lines and because stable transfection of mutant p53 did not over-rule the inhibitory eect, we can conclude that the inhibition of DE1B replication is not caused by functionally wt p53. The data we obtained with the adenovirus mutant show that an increasing number of hexon positive cells is detectable at later time points post-infection, indicating that the replication of the adenovirus mutant is not completely blocked but rather delayed in the tumor cells. In these experiments the virus produced in the primary infected cells can, after release in the tissue culture medium subsequently re-infect the surrounding cells. As mentioned above it has been described that the large E1B protein has a role in several processes involved in viral replication (Babiss and Ginsberg, 1984; Ornells and Shenk, 1991) so in the absence of the large E1B protein viral replication and subsequent reinfection of the surrounding cells might occur less eciently. On the other hand, a decreased virus burst size of the adenovirus mutant has been described by Goodrum and Ornelles (1997) and Yew et al. (1990) . It can be imagined that, when less virus particles are produced by the DE1B virus after infection with a low MOI, re-infection of the surrounding cells will occur less eciently compared to the wt adenovirus. In addition, because in the highly infective C33A cells replication of the DE1B virus is only slightly repressed it is possible that the infectivity of the cells might contribute to the observed eect.
It has recently been reported that adenovirus infection can only cause lytic cell death in cells expressing wt p53 (Hall et al., 1998) . The data we obtained show clear CPE in p53-pro®cient as well as -de®cient cells as long as the cells take up adenovirus eciently and support the replication of the Ad E proteins. It has been shown previously that the Ad E proteins inhibit the transcriptional activity of p53 (Dobner et al., 1996; Steegenga et al., 1995 Steegenga et al., , 1996 Yew and Berk, 1992) and besides, down-regulate the expression of this tumor suppressor gene (Querido et al., 1997; Steegenga et al., 1998) . These results imply that inactivation of p53 is important for adenovirus replication. In cells infected with wt adenovirus we observed down-regulation of the p53 expression prior to killing of the cells by the virus. However, in cells infected with high concentrations the DE1B virus p53 expression is not down-regulated and the CPE pattern was highly comparable to that of wt virus.
In summary, our results indicate ®rst that, in agreement with previous results, there is a remarkable dierence between the eciency of replication of the wt and DE1B adenovirus in primary cells. This indicates that the DE1B virus is, in general, a very inecient virus and thus a rather safe virus for primary cells. Secondly, our results also show that there is signi®cantly less dierence in replication eciency of the wt and DE1B virus in tumor cells. Thirdly, our results shown that the p53 status of the cell does not play a signi®cant role in the eciency of the DE1B virus to replicate in tumor cells. In addition, we also found that no wt p53 was required by the adenovirus to induce lytic infection. Finally, we show that infectivity and the ability to express the early viral genes are important parameters that determine the eciency of adenovirus replication in human cells. From these results we conclude that the DE1B virus might be an oncolytic virus for a restricted subset of p53-pro®cient and -de®cient tumors.
Material and methods
Tissue culture and cell lines
The rhabdoid kidney tumor cell line G401 subclone G401.6TG.C6 (Weissman et al., 1987) and the cell lines MD468 (Nigro et al., 1989a) , C33A (Schener et al., 1991), U2OS (Diller et al., 1990) , Saos2 (Chandar et al., 1992) , MCF7, 911 (Fallaux et al., 1996) , Hep3B (Puisieux et al., 1993) and the primary cells VH10 and GM1492 were grown in Dulbecco's modi®ed Eagle's medium (DMEM) plus 10% FBS. The primary foreskin keratinocytes and HPV-transformed keratinocytes FK18B (Steenbergen et al., 1996) were grown in serum-free Keratinocyte Growth Medium (Life Technology, Breda, The Netherlands) supplemented with bovine pituitary extract (50 mg/ml), epidermal growth factor 5 ng/ml) and L-glutamine (2 mM). The mutant p53-expressing stable transfectants were obtained by transfecting G401 cells with the pCMVp53-273 construct. The Ad5 E1B expressing stable transfectant G55C5 has previously been described (Steegenga et al., 1998) . All stable transfectants were cultured in the same medium as the parental G401 cell line with addition of the G418 (300 mg/ml).
Adenoviruses and virus techniques
The wt Ad5, DE1B (=dl1520 or ONYX-015) (Bischo et al., 1996) and CMV-lacZ adenovirus (Kolls et al., 1994) have been grown and puri®ed as previously described (Steegenga et al., 1998) . Concentration of the viruses has been determined by plaque assay in 911 cells as described previously (Steegenga et al., 1998) . For the infection experiments the cells were split 1 day prior to the infection. For the infectivity tests cells were infected on 6-well dishes by incubating the cells for 30 min at 378C with the CMVLacZ adenovirus diluted in 200 ml PBS+2% FCS. Afterwards, the virus was removed and normal tissue culture medium was added to the cells. Twenty-four hours post-infection the cells were ®xed and stained by b-galactosidase staining as described previously (Fallaux et al., 1996) . The infectivity of all cell types was examined at least two times with reproducible result. Analysis of primary and secondary infections by wt and DE1B adenovirus were performed on 5 cm petridishes by incubating the cells for 30 min at 378C with the concentrations of wt or DE1B virus as depicted in the legend of Figures 2, 3, 4 and 5 in a volume of 500 ml PBS+2% FCS. Afterwards, the virus was removed and normal tissue culture medium was added to the cells. After isolation, cells were ®xed with 80% ethanol over night followed by incubation with the a-hexon antibody (Imagen TM , Dako) and analysed by Fluorescent Activated Cell Sorter (Becton Dickinson). All infections were performed at least twice in independent experiments with reproducible results.
Plasmids, transient transfections and luciferase assays
Hep3B cells were transiently transfected by the calciumphosphate precipitation method (van der Eb and Graham, 1980) on 6-well plates. The samples contained 0.5 mg of either the pXALuc or the pOLXALuc reporter construct, 1.0 mg of CMVLacZ and the total amount of DNA was adjusted to 10 mg with salmon sperm DNA. All precipitates were made in triplicate and the error bars in Figure 4c indicate the variation between the precipitates.
Exponentially growing cells were transfected overnight. The next morning, cells were washed twice with PBS and 24 h later, lysates were made in luciferase lysis buer (0.1 M Tris-H 2 PO 4 pH 7.8, 1% Triton, 15% glycerol, 2 mM DTT, 8 mM MgCl 2 ). After 15 min incubation at room temperature cell debris was removed by 1 min centrifugation. The luciferase activity was measured with a Lumat LB9507 (EG&G Berthold) in 50 ml of the lysates after addition of 100 ml of Luciferin (Boehringer, Mannheim). In addition, of each sample the b-galactosidase activity was determined. Therefore, 30 ml of lysate was incubated with 1 mM MgCl 2 , 45 mM b-mercaptoethanol, 0.26 mg o-nitrophenyl-b-D-galactopyranoside, 0.1 M sodium phosphate buer [pH 7 .5] at 378C until a faint yellow color developed. The reaction was stopped by addition of 500 ml ice cold water and the extinction was measured at a wavelength of 420 nm. For the results presented in Figure 2c the measured luciferase activity was calculated for equal amounts of b-galactosidase activity. Subsequently, the luciferase activity in the pXALuc samples was adjusted to one and the fold induction of the pOLXALuc construct was calculated. The experiment has been performed twice with reproducible results.
Cell cycle analysis
Exponentially growing cells were irradiated with X-rays (5 Gy) Twenty hours after treatment, unirradiated and irradiated cells were labeled for 30 min with 20 mM BrdU. The cells were washed twice with PBS and harvested by trypsinization. The cells were washed again with PBS, ®xed in 70% ethanol overnight. Subsequently, the cells were centrifuged and the pellet was resuspended in 2 N HCl. Cells were incubated for 12 min at 378C and after washing incubated with aBrdU (Becton Dickinson). Afterwards, cells were incubated with propidium-iodide and RNAse and 5000 cells were analysed on a FACScan¯ow cytometer (Becton Dickinson) for DNA-content and BrdU incorporation.
CPE assay
Cells were split one day prior to infection and seeded out on 6-well plates. Infections were carried out as described above. At the time points indicated in the legends of Figures 4 and 5 the wells were washed twice with PBS followed by the addition of 1 ml BCA (Pierce) reagent containing 0.1 M NaOH. The extinction was measured at 562 nm.
Western immunoblotting
Lysates of the (mock) infected cells were made in IPB 0.7 (20 mM triethanolamine Hcl [TEA; pH 7.8], 0.7 M NaCl, 0.5% Np40, 0.2% deoxycholate, 1 mM PMSF, 1 mM orthovanadate, 1 mM Leupeptin, 0.5 mM trypsin inhibitor and 0.1 mM aprotinin). Lysates were cleared by centrifugation at 14 000 r.p.m. for 10 min. Protein concentrations of the lysates were measured by the Bradford Assay (Biorad). Ten mg of the lysates were examined by Western immunoblotting. The samples were boiled for 5 min in Laemmli sample buer and subsequently separated on 10% SDSpolyacrylamide gels. Subsequently, the proteins were blotted onto Protran nitrocellulose membrane (Scheicher and Schuell). The membranes were incubated with the antibodies: DO-1 (SanverTECH, p53-speci®c), M73 (E1A-speci®c), 1G11 (21K-E1B-speci®c) or anti-actin (SanverTech). After incubation with HRP-conjugated amouse-, arabbit-or a-rat secondary antibodies, immune complexes were detected by enhanced chemiluminescence (Amersham).
